A Training Program of Drug Allergy for Healthcare Professionals
NCT06399601 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-05-06
Summary
Drug allergy is often under-recognized, yet over- (mistakenly) diagnosed, especially in Hong Kong. There is also a dire shortage of allergy specialists and facilities to tackle the overwhelming drug allergy pandemic. Fortunately, when trained, non-specialist physicians and nurses have demonstrated comparable capabilities in drug allergy evaluation compared to specialists. To potentially promote and propagate the role of non-specialist physicians and nurses toward drug allergy care, the investigators propose a study to investigate the impact of an intensive and focused drug allergy educational course conducted at the University of Hong Kong.
Conditions
- Drug Allergy
Interventions
- OTHER
-
Drug allergy training program
Two identical didactic courses on drug allergy were designed. Each course will last 12 hours and conducted over 2 consecutive days (6 hours each day). All candidates will attend physically and on-site. Various aspects of drug allergy with pre-set learning objectives will be taught in-person by instructors (physicians or nurses specializing in drug allergy nominated by the University of Hong Kong). Course materials and instructors will be identical for each course.
Sponsors & Collaborators
-
The University of Hong Kong
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-09
- Primary Completion
- 2024-12-16
- Completion
- 2024-12-16
Countries
- Hong Kong
Study Locations
More Related Trials
-
Nasal Allergen Challenge - Reproducibility of Biomarkers and Effect of Topical Steroid Treatment
NCT03431961 ·Status: UNKNOWN ·Phase: NA
-
Extended Open Challenge in Patients With a History of Drug Eruption Following Beta-lactam Treatment
NCT01520181 ·Status: COMPLETED ·Phase: NA
-
Randomized Evaluation of Ten Allergy Skin Prick Test Devices
NCT03509766 ·Status: COMPLETED ·Phase: NA
-
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
NCT05098522 ·Status: COMPLETED ·Phase: PHASE2
-
Allergy UK Research and Development Nurse Project
NCT03826953 ·Status: COMPLETED ·Phase: NA
-
Leukotriene Antagonism in Recruitment of CD49d Expressing Neutrophils in Atopic Subjects
NCT03039101 ·Status: COMPLETED ·Phase: NA
-
Local IgE in Subjects With Allergic or Non-allergic Rhinitis
NCT02810535 ·Status: COMPLETED ·Phase: NA
-
Acquisition and Long-term Observation of Patients With Severe Allergic Reactions
NCT05210543 ·Status: RECRUITING
-
Effect of Intranasal Anti-IgE Antibodies on IgE Production
NCT03019237 ·Status: COMPLETED ·Phase: NA
-
A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy
NCT00250263 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor Antagonist
NCT03293225 ·Status: COMPLETED
-
Exploration of the Optimal Dosage of Cetirizine in the Treatment of Allergic Diseases in Chinese Children
NCT06288334 ·Status: RECRUITING ·Phase: PHASE4
-
Allergic Rhinitis Improvement Through Strategic Education: The ARISE Trial
NCT06686446 ·Status: TERMINATED ·Phase: NA
-
Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
NCT01963741 ·Status: COMPLETED ·Phase: NA
-
Allergic Versus Non Allergic Hypersensitivity Drug Reaction (BdDAllergo)
NCT03369509 ·Status: TERMINATED
-
Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.
NCT02653339 ·Status: UNKNOWN ·Phase: NA
-
A Novel Biologic Therapy for Perennial Allergic Rhinitis
NCT03360071 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis
NCT02230696 ·Status: COMPLETED ·Phase: PHASE3
-
Standardising Nasal Allergen Challenge in Adult With Hay Fever
NCT04078009 ·Status: COMPLETED ·Phase: NA
-
Effect and Safety of Fexofenadine Hydrochloride vs Placebo in Patients With Acute Myocardial Infaction: A Randomized Clinical Trial
NCT06548204 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
NCT04853992 ·Status: COMPLETED ·Phase: PHASE2
-
Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis (Hay Fever)
NCT00348361 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
NCT02024152 ·Status: COMPLETED ·Phase: PHASE1
-
The Prevalence and Clinical Characteristics of Children With Local Allergic Rhinitis
NCT02271620 ·Status: COMPLETED ·Phase: NA
-
Comparability and Standardization of Controlled Allergen Challenge Facilities
NCT02543346 ·Status: COMPLETED ·Phase: PHASE4